Peptide Network:Peptides Looksmaxxing·Maxxing Peptides·Peptide Scientists
#1
Clav's Stack
>98%
HPLC Verified
Every Order
COA Included
24+
Products
$200+
Free Shipping
Always
3rd-Party Tested
Back to Products
Dual GIP / GLP-1 Receptor Agonist
Tirzepatide

Dual GIP / GLP-1 Receptor Agonist

Buy Tirzepatide

Not For Human Use, Lab Use Only.

Dual GIP/GLP-1 receptor pharmacology—listed as a research-grade lyophilized SKU; verify regulatory status and literature independently.

Select size

$134.99In Stock
Buy Tirzepatide 15mg

≥98% Purity

HPLC Verified

Research Grade

Lyophilized

Fast Shipping

Free $200+

Specifications

CAS Number2023788-19-2
MechanismGIP + GLP-1 dual receptor agonist
Molecular Weight~4,813 Da
Storage−20°C (lyophilized) · 4°C in solution up to 4 weeks
Purity≥98% HPLC verified

Tirzepatide — Receptor Pathways

M1

GIP Receptor Agonism

Tirzepatide co-activates GIP and GLP-1 receptors. Reviews describe glucose-dependent insulin effects and adipose/muscle signaling for the GIP arm alongside GLP-1–associated satiety and incretin biology. This page avoids 'who lost more weight' style summaries.

M2

GLP-1 Receptor Agonism

GLP-1 activation reduces appetite via hypothalamic pathways, slows gastric emptying (increasing satiety), and potentiates insulin secretion. Tirzepatide's GLP-1 component is structurally biased compared to native GLP-1, producing a different receptor activation profile than semaglutide.

M3

Adipose Tissue Remodeling

Preclinical and imaging-heavy publications discuss fat-depot effects for dual incretin agonists. This catalog does not reproduce endpoint statistics from those studies.

Tirzepatide — Research-Use Notice

This page summarizes identity, purity, and handling context for catalog navigation. It is not medical advice, a drug label, or a summary of clinical outcomes for any use. Materials are sold for legitimate laboratory research only; verify requirements with your institution and the supplier.

Buying Tirzepatide: Concentration Reference

Figures below are volumetric / handling notes for lyophilized material only. They are not therapeutic dosing, efficacy claims, or instructions for use in humans or animals.

Protocol
Dose
Frequency
Notes
Standard Weekly Injection
2.5–15 mg/week
Once weekly
Illustrative weekly mg ranges sometimes used in published titration discussions for this drug class—laboratory reference only.
Accelerated Titration
5–15 mg/week
Once weekly
Some publications discuss faster escalation schedules; this site does not endorse any administration plan.
Compound note

Tirzepatide — Reconstitution Notes

15mg vial + 1.5mL BAC water = 10mg/mL. Example draws: 1.0mL = 10mg; 0.5mL = 5mg—solution math only.

Tirzepatide is well-characterized for reconstitution — dissolves within 1–2 min of gentle swirling. Stable post-reconstitution at 2–8°C for 4 weeks.

Tirzepatide — Pair This With

BPC-157

BPC-157 is a separate repair-axis peptide commonly purchased alongside metabolic SKUs for unrelated laboratory work.

GHK-Cu

GHK-Cu is a dermal-research staple; buyers often add it to the same order for skin-matrix studies.

Tirzepatide

from $134.99

Shop Now